Paris - Delayed Quote EUR
Transgene SA (TNG.PA)
1.0800
+0.1800
+(20.00%)
At close: June 4 at 5:35:22 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 1 |
Avg. Estimate | 0 | 0 | -0.27 | -0.34 |
Low Estimate | 0 | 0 | -0.27 | -0.34 |
High Estimate | 0 | 0 | -0.27 | -0.34 |
Year Ago EPS | -- | -- | -0.29 | -0.27 |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 1 |
Avg. Estimate | -- | -- | 6.7M | 6.7M |
Low Estimate | -- | -- | 6.7M | 6.7M |
High Estimate | -- | -- | 6.7M | 6.7M |
Year Ago Sales | -- | -- | 6.35M | 6.7M |
Sales Growth (year/est) | -- | -- | 5.46% | 0.00% |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | -0.27 | -0.34 |
7 Days Ago | 0 | 0 | -0.27 | -0.34 |
30 Days Ago | 0 | 0 | -0.27 | -0.34 |
60 Days Ago | 0 | 0 | -0.27 | -0.34 |
90 Days Ago | 0 | 0 | -0.27 | -0.34 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | 1 |
Up Last 30 Days | -- | -- | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
TNG.PA | -- | -- | 6.90% | -25.93% |
S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Related Tickers
OSE.PA OSE Immunotherapeutics SA
6.25
+1.38%
SIGHT.PA GenSight Biologics S.A.
0.2045
-5.76%
NANO.PA Nanobiotix S.A.
4.0100
+7.65%
DBV.PA DBV Technologies S.A.
1.3980
-0.71%
ALSEN.PA Sensorion SA
0.4000
+8.11%
POXEL.PA Poxel S.A.
0.6640
-6.87%
ALTHX.PA Theranexus Société Anonyme
0.9880
-1.00%
ALTME.PA TME Pharma N.V.
0.0870
+3.57%
IPH.PA Innate Pharma S.A.
1.9300
-0.72%
NYKD.OL Nykode Therapeutics AS
1.6670
+0.42%